Immune Pharmaceuticals Inc (fka IMNPQ)

[lipster]

Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) traded 3.87 Million shares on last trading day with closing price of $0.32. Stock value has moved between $0.2 – 1.6 in last one year. Analyst’s mean target price for Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) is $44.00 while analysts mean recommendation is 1.50. IMNP EPS growth this year and EPS growth next year is 38.20%, 105.40% respectively.

Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) announced that it has entered into a stock purchase agreement with an existing stockholder for the sale of 4,000,000 shares of the Company’s common stock at a fixed price of$0.50 per share, for gross proceeds of $2,000,000. There are no warrants, no restrictive covenants, and no restrictions on use of proceeds.